Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00111813
Brief Title: Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))

First Submitted : May 25, 2005
First Submitted that Met QC Criteria : May 25, 2005
First Posted : May 26, 2005 (Estimate)

Results First Submitted : March 10, 2011
Results First Submitted that Met QC Criteria : March 10, 2011
Results First Posted : April 6, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : May 5, 2015
Last Update Posted : May 21, 2015 (Estimate)